Author:
Nie Chaoqun,Ding Xue,A Rong,Zheng Min,Li Zhenning,Pan Shuang,Yang Wei
Funder
Postdoctoral Scientific Research Development Fund of Heilongjiang Province
National Natural Science Foundation of China
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference37 articles.
1. Benjamin, E.J., et al., Heart Disease and Stroke Statistics-2019 update: a report from the American Heart Association. Circulation, 2019. 139(10): p. e56-e528.
2. Feher, A., et al., Prevention and treatment of no-reflow phenomenon by targeting the coronary microcirculation. Rev. Cardiovasc. Med., 2014. 15(1): p. 38–51.
3. Evolving therapies for myocardial ischemia/reperfusion injury;Ibanez;J. Am. Coll. Cardiol.,2015
4. The “no-reflow” phenomenon after temporary coronary occlusion in the dog;Kloner;J. Clin. Invest.,1974
5. Eeckhout, E. and M.J. Kern, The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur. Heart J., 2001. 22(9): p. 729–39.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献